St. Vincent's Screening To Prevent Heart Failure Study (STOP-HF)
St. Vincent's Screening To Prevent Heart Failure (STOP-HF) Study Using Natriuretic Peptides to Identify and Prevent Progression of Left Ventricular Dysfunction in Community Based, Asymptomatic, At-risk Individuals.
Sponsor: Crofton Cardiac Centre, Dublin
This NA trial investigates Diabetes and Hypertension and is currently completed. Crofton Cardiac Centre, Dublin leads this study, which shows 8 recorded versions since 2005 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
8 versions recorded-
Jan 2026 — Present [monthly]
Completed NA
-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Aug 2018 — Jan 2021 [monthly]
Completed NA
Status: Unknown Status → Completed · Phase: PHASE4 → NA
▶ Show 3 earlier versions
-
Jun 2018 — Aug 2018 [monthly]
Unknown Status PHASE4
-
Aug 2017 — Jun 2018 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jan 2017 — Aug 2017 [monthly]
Recruiting PHASE4
First recorded
Jan 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Crofton Cardiac Centre, Dublin
- St Vincent's University Hospital, Ireland
- The Heartbeat Trust
- University College Dublin
For direct contact, visit the study record on ClinicalTrials.gov .